Movement Disorder and Neuromodulation Unit, Department of Neurology, Charité Universitaetsmedizin Berlin, 10117 Berlin, Germany.
Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Sensors (Basel). 2023 May 31;23(11):5238. doi: 10.3390/s23115238.
Bradykinesia is a cardinal hallmark of Parkinson's disease (PD). Improvement in bradykinesia is an important signature of effective treatment. Finger tapping is commonly used to index bradykinesia, albeit these approaches largely rely on subjective clinical evaluations. Moreover, recently developed automated bradykinesia scoring tools are proprietary and are not suitable for capturing intraday symptom fluctuation. We assessed finger tapping (i.e., Unified Parkinson's Disease Rating Scale (UPDRS) item 3.4) in 37 people with Parkinson's disease (PwP) during routine treatment follow ups and analyzed their 350 sessions of 10-s tapping using index finger accelerometry. Herein, we developed and validated ReTap, an open-source tool for the automated prediction of finger tapping scores. ReTap successfully detected tapping blocks in over 94% of cases and extracted clinically relevant kinematic features per tap. Importantly, based on the kinematic features, ReTap predicted expert-rated UPDRS scores significantly better than chance in a hold out validation sample (n = 102). Moreover, ReTap-predicted UPDRS scores correlated positively with expert ratings in over 70% of the individual subjects in the holdout dataset. ReTap has the potential to provide accessible and reliable finger tapping scores, either in the clinic or at home, and may contribute to open-source and detailed analyses of bradykinesia.
运动徐缓是帕金森病(PD)的主要特征。运动徐缓的改善是有效治疗的重要标志。手指叩击通常用于评估运动徐缓,但这些方法主要依赖于主观的临床评估。此外,最近开发的自动化运动徐缓评分工具是专有的,不适合捕捉日内症状波动。我们在常规治疗随访中评估了 37 名帕金森病患者(PwP)的手指叩击(即统一帕金森病评定量表(UPDRS)第 3.4 项),并使用食指加速度计分析了他们的 350 次 10 秒叩击。在此,我们开发并验证了 ReTap,这是一种用于自动预测手指叩击评分的开源工具。ReTap 成功地在超过 94%的情况下检测到叩击块,并为每次叩击提取了临床相关的运动学特征。重要的是,基于运动学特征,ReTap 在保留样本(n=102)中比随机预测专家评分的效果要好。此外,在保留数据集中的 70%以上的个体受试者中,ReTap 预测的 UPDRS 评分与专家评分呈正相关。ReTap 有可能在诊所或家中提供可及且可靠的手指叩击评分,并有助于对运动徐缓进行开源和详细分析。